Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CDK12 inhibitor

DRUG CLASS:

CDK12 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

EWSR1-FLI1 fusion	Ewing Sarcoma	EWSR1-FLI1 fusion	Ewing Sarcoma	CDK12 inhibitor Sensitive: D – Preclinical CDK12 inhibitor Sensitive : D	CDK12 inhibitor Sensitive: D – Preclinical CDK12 inhibitor Sensitive : D
EGFR mutation	Lung Adenocarcinoma	EGFR mutation	Lung Adenocarcinoma	osimertinib + AU-16770 Sensitive: D – Preclinical osimertinib + AU-16770 Sensitive : D	osimertinib + AU-16770 Sensitive: D – Preclinical osimertinib + AU-16770 Sensitive : D
EGFR mutation	Lung Adenocarcinoma	EGFR mutation	Lung Adenocarcinoma	osimertinib + AU-15506 Sensitive: D – Preclinical osimertinib + AU-15506 Sensitive : D	osimertinib + AU-15506 Sensitive: D – Preclinical osimertinib + AU-15506 Sensitive : D